Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

被引：0
|
作者：
Eric Southam
Jackie Cilia
Jane E. Gartlon
Marie L. Woolley
Laurent P. Lacroix
Carol A. Jennings
Jane E. Cluderay
Charlie Reavill
Claire Rourke
David M. Wilson
Lee A. Dawson
Andrew D. Medhurst
Declan N. C. Jones
机构：
[1] GlaxoSmithKline,
来源：
Psychopharmacology | 2009年 / 201卷
关键词：
Antipsychotic; Autoradiography; c-; Cognition; Dopamine; Haloperidol; Histamine; Microdialysis; Prepulse inhibition; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 494
页数：11
相关论文
共 50 条
  • [21] Pharmacological effects of a histamine H3 receptor antagonist to neuropathic pain
    Yoshikawa, Takeo
    Matsuzawa, Takuro
    Mogi, Asuka
    Mogilevskaya, Maria
    Nakamura, Tadaho
    Yanai, Kazuhiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S187 - S187
  • [22] Drug-drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H3 receptor antagonist
    Terasaka, Shuichi
    Hachiuma, Kenji
    Mano, Yoko
    Onishi, Koichi
    Kitajima, Iwao
    Nishino, Izumi
    Endo, Hiromi
    XENOBIOTICA, 2021, 51 (07) : 786 - 795
  • [23] Therapeutic potential histamine H3 receptor agonists and antagonists
    Leurs, R
    Blandina, P
    Tedford, C
    Timmerman, H
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) : 177 - 183
  • [24] Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems
    Hsieh, Gin C.
    Honore, Prisca
    Pai, Madhavi
    Wensink, Erica J.
    Chandran, Prasant
    Salyers, Anita K.
    Wetter, Jill M.
    Zhao, Chen
    Liu, Huaqing
    Decker, Michael W.
    Esbenshade, Timothy A.
    Cowart, Marlon D.
    Brioni, Jorge D.
    BRAIN RESEARCH, 2010, 1354 : 74 - 84
  • [25] A comparison of the effects of the novel histamine H3 receptor antagonist GSK189254 and clozapine on regional c-Fos expression in rat brain
    Southam, E.
    Jennings, C. A.
    Cilia, J.
    Gartlon, J.
    Hill, M. D.
    Cluderay, J. E.
    Jones, D. N. C.
    Medhurst, A. D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S144 - S144
  • [26] Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H1 and H3 receptors
    Slack, R. J.
    Russell, L. J.
    Hall, D. A.
    Luttmann, M. A.
    Ford, A. J.
    Saunders, K. A.
    Hodgson, S. T.
    Connor, H. E.
    Browning, C.
    Clark, K. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (06) : 1627 - 1641
  • [27] THERAPEUTIC POTENTIAL OF HISTAMINE H3 RECEPTOR ANTAGONISTS IN DEMENTIAS
    Chazot, Paul L.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (02) : 99 - 103
  • [28] Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist
    Hancock, AA
    Bennani, YL
    Bush, EN
    Esbenshade, TA
    Faghih, R
    Fox, GB
    Jacobson, P
    Knourek-Segel, V
    Krueger, KM
    Nuss, ME
    Pan, JB
    Shapiro, R
    Witte, DG
    Yao, BB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 487 (1-3) : 183 - 197
  • [29] Novel therapeutic approach in narcolepsy: clinical trials of an antagonist/inverse agonist of the histamine H3 receptor
    Dauvilliers, Y.
    JOURNAL OF SLEEP RESEARCH, 2014, 23 : 75 - 75
  • [30] The Akt/GSK-3β axis as a new signaling pathway of the histamine H3 receptor
    Bongers, Gerold
    Sallmenj, Tina
    Passani, Maria Beatrice
    Mariottini, Chiara
    Wendelin, Dominique
    Lozada, Adrian
    van Marle, Andre
    Navis, Marjon
    Blandina, Patrizio
    Bakker, Remko A.
    Panula, Pertti
    Leurs, Rob
    JOURNAL OF NEUROCHEMISTRY, 2007, 103 (01) : 248 - 258
12345